1311P Phase II, Open-Label Study of Frontline Tusamitamab Ravtansine with Pembrolizumab ± Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: Updated Results from CARMEN-LC05 Trial
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined